Michael Hurwitz
8PUBLICATIONS
85CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Feb 13, 2026
Ex Vivo Expansion of Melanoma Tumor-Infiltrating Lymphocytes Leads to a Dominant Exhausted T-cell Population with a Lack of Memory Markers.Gianfilippo Coppola, Samuel Kerr, Pei-Chun Cha
|Feb 24, 2025
Presence of Tertiary Lymphoid Structures and Exhausted Tissue-Resident T Cells Determines Clinical Response to PD-1 Blockade in Renal Cell Carcinoma.Miya B Hugaboom, Lena V Wirth, Kelly Street
|Nov 15, 2024
Sorafenib or anthracycline-based chemotherapy for progressive desmoid tumors.Philippos Apolinario Costa, Arshia Arora, Yannelys Fernandez
|Aug 06, 2024
TIGIT expression in renal cell carcinoma infiltrating T cells is variable and inversely correlated with PD-1 and LAG3.Oscar Perales, Lucia Jilaveanu, Adebowale Adeniran
|Apr 07, 2024
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma.Sumanta K Pal, Ben Tran, John B A G Haanen
|Apr 20, 2022
Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A).Michael B Atkins, Opeyemi A Jegede, Naomi B Haas
Pageof 2
Frequent Collaborators
3 joint publications
David Braun
2 joint publications
Elizabeth R Plimack
2 joint publications
Harriet M Kluger
2 joint publications
Sabina Signoretti
2 joint publications
Naomi B Haas
2 joint publications
David F McDermott
2 joint publications
Michael B Atkins
2 joint publications
Mark Stein
2 joint publications
Thomas Denize
2 joint publications
Opeyemi A Jegede
